Will Merck achieve the full $600 million earnout based on CN201 performance milestones by December 31, 2025?

What will be Merck's revenue from CN201 by December 31, 2025?

Will Merck's stock price increase by more than 10% by December 31, 2024?

What will be the revenue generated by Merck's CN201 therapy by December 31, 2026?

Will Merck's CN201 therapy receive FDA approval for autoimmune diseases by December 31, 2024?

Will Merck's CN201 therapy receive FDA approval for B-cell malignancies by December 31, 2024?

What market share will Merck's CN201 therapy achieve in the autoimmune diseases treatment market by December 31, 2025?

What market share will Merck's CN201 therapy achieve in the B-cell malignancies treatment market by December 31, 2025?

What will be the revenue from Merck's CN201 therapy in its first year post-approval?

What will be the Phase III trial results for CN201 by June 30, 2025?

Will CN201 be FDA approved for B-cell malignancies by August 9, 2025?

Will CN201 be FDA approved for autoimmune diseases by August 9, 2025?

What will be the competitive response to CN201 by August 9, 2025?

Will Merck complete the acquisition of CN201 therapy from Curon by December 31, 2024?

For which condition will Merck's CN201 therapy be used by December 31, 2025?

What significant milestone will Merck's CN201 therapy achieve by December 31, 2025?

Will Merck announce a new clinical trial for CN201 therapy by June 30, 2025?

Will Merck receive FDA approval for CN201 therapy by December 31, 2025?